 |
 |

Parental Reactions to Information About Increased Genetic Risk of Type 1 Diabetes Mellitus in Infants
Paula Simonen, PhLic;
Tapio Korhonen, PhD;
Tuula Simell, MPH, PhD;
Päivi Keskinen, MD, PhD;
Maarit Kärkkäinen, MHSci;
Mikael Knip, MD, PhD;
Jorma Ilonen, MD, PhD;
Olli Simell, MD, PhD
Arch Pediatr Adolesc Med. 2006;160:1131-1136.
Objective To assess the anxiety, emotions, thoughts, and coping behaviors of parents 1 week after they receive the results of screening of their infant's genetic risk of type 1 diabetes mellitus.
Design Survey.
Setting The population-based Type 1 Diabetes Prediction and Prevention project conducted in Turku.
Participants Parents of 443 consecutive high-risk infants and 506 next-born low-risk infants.
Interventions An infant's genetic risk of type 1 diabetes mellitus was measured from cord blood. High-risk information was delivered by telephone and low-risk information by mail 4 weeks later.
Main Outcome Measures Anxiety measured using the state anxiety scale of the State-Trait Anxiety Inventory, and feelings, thoughts, and coping behaviors extracted from the questionnaire.
Results One week after obtaining the results, 67% of mothers and 63% of fathers of high-risk children and 58% of mothers and 54% of fathers of low-risk children had returned the questionnaire. Anxiety levels of parents of high-risk infants were similar to those of parents of low-risk infants (P = .86). More than 90% of the parents thought that it was good to know about the risk. Fifty-five percent of mothers and 37% of fathers of high-risk infants expressed modest worry. Increased anxiety was connected with other stressful life events, catastrophizing thoughts of diabetes mellitus risk, and emotion-focused or avoiding coping attitudes.
Conclusions Learning about their infant's genetic diabetes mellitus risk induces only mild anxiety in most parents. Identifying the few parents with stronger anxiety helps focus intensified counseling.
Author Affiliations: Departments of Psychology (Ms Simonen and Dr Korhonen), Child Psychiatry (Dr Korhonen), Pediatrics (Drs T. Simell and O. Simell and Ms Kärkkäinen), and Virology (Dr Ilonen), University of Turku, Turku; Hospital District of Satakunta, Pori (Ms Simonen); Department of Pediatrics, Tampere University School of Medicine, Tampere (Dr Keskinen); and Hospital for Children and Adolescents, University of Helsinki, Helsinki (Dr Knip), Finland.
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
RELATED LETTERS
Against Newborn Screening for Type 1 Diabetes
Lainie Friedman Ross
Arch Pediatr Adolesc Med. 2007;161(6):616-617.
EXTRACT
| FULL TEXT
Against Newborn Screening for Type 1 DiabetesReply
Olli Simell
Arch Pediatr Adolesc Med. 2007;161(6):617-618.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
From Genetic Risk Awareness to Overt Type 1 Diabetes: Parental stress in a placebo-controlled prevention trial
Goldstein et al.
Diabetes Care 2009;32:2181-2183.
ABSTRACT
| FULL TEXT
Against Newborn Screening for Type 1 Diabetes--Reply
Simell
Arch Pediatr Adolesc Med 2007;161:617-618.
FULL TEXT
Against Newborn Screening for Type 1 Diabetes
Ross
Arch Pediatr Adolesc Med 2007;161:616-617.
FULL TEXT
Parents' Reaction to Information About their Newborn's Risk of Diabetes
Varma
AAP Grand Rounds 2007;17:43-43.
FULL TEXT
|